Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation.

Abstract

Hemorrhagic disseminated intravascular coagulation (DIC) associated with the presence of underlying advanced or metastatic tumors are often difficult to control by conventional methods. We report the use of recombinant activated factor VII (rFVIIa) in patients with cancer and bleeding secondary to DIC. A total of 18 patients with cancer met pre-defined… (More)

Topics

Cite this paper

@article{Sallah2004RecombinantAF, title={Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation.}, author={Sabah Sallah and Aisha Husain and Nam P. Nguyen}, journal={Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis}, year={2004}, volume={15 7}, pages={577-82} }